Literature DB >> 8452348

Expression of the tetK gene from Staphylococcus aureus in Escherichia coli: comparison of substrate specificities of TetA(B), TetA(C), and TetK efflux proteins.

G G Guay1, D M Rothstein.   

Abstract

The tetK gene, which encodes a tetracycline efflux pump from Staphylococcus aureus, was expressed in Escherichia coli by using an inducible, low-level expression system. The tetK gene, as well as the tetA(B) gene from the transposon Tn10 and the tetA(C) gene from plasmid pBR322, was subjected to the regulatory control of the lac repressor, and resistance to tetracycline was measured as a function of the isopropyl-beta-D-thiogalactopyranoside concentration. The maximum resistance of the E. coli strain containing the tetK construct was comparable to the maximum resistance of the strain containing the tetA(C) construct but was less than the resistance of the strain containing the tetA(B) construct. Overexpression of the tetK, tetA(B), or tetA(C) genes was toxic. When expression was regulated so that resistance to tetracycline was comparable, then the TetA(B) and TetA(C) proteins conferred very similar levels of resistance to a variety of tetracycline derivatives. In contrast, the TetK protein was less capable of conferring resistance to the tetracycline derivatives minocycline, 6-deoxy-6-demethyltetracycline, and doxycycline. The implications for the recognition of various tetracycline substituents by the TetK protein are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8452348      PMCID: PMC187637          DOI: 10.1128/AAC.37.2.191

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  44 in total

1.  Detection of an inducible membrane protein associated with R-factor-mediated tetracycline resistance.

Authors:  S B Levy; L McMurry
Journal:  Biochem Biophys Res Commun       Date:  1974-02-27       Impact factor: 3.575

2.  Nucleotide sequence of the Tn10 encoded tetracycline resistance gene.

Authors:  W Hillen; K Schollmeier
Journal:  Nucleic Acids Res       Date:  1983-01-25       Impact factor: 16.971

3.  Tn1721-encoded tetracycline resistance: mapping of structural and regulatory genes mediating resistance.

Authors:  J Altenbuchner; K Schmid; R Schmitt
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

4.  Nucleotide sequence and phylogeny of the tet(L) tetracycline resistance determinant encoded by plasmid pSTE1 from Staphylococcus hyicus.

Authors:  S Schwarz; M Cardoso; H C Wegener
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

5.  Action of 12 tetracyclines on susceptible and resistant strains of Staphylococcus aureus.

Authors:  D Sompolinsky; J Krausz
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

6.  Construction and characterization of new cloning vehicles. II. A multipurpose cloning system.

Authors:  F Bolivar; R L Rodriguez; P J Greene; M C Betlach; H L Heyneker; H W Boyer; J H Crosa; S Falkow
Journal:  Gene       Date:  1977       Impact factor: 3.688

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  A multifunctional gene (tetR) controls Tn10-encoded tetracycline resistance.

Authors:  C F Beck; R Mutzel; J Barbé; W Müller
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

9.  Mutations in multicopy Tn10 tet plasmids that confer resistance to inhibitory effects of inducers of tet gene expression.

Authors:  H S Moyed; K P Bertrand
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

10.  Multicopy Tn10 tet plasmids confer sensitivity to induction of tet gene expression.

Authors:  H S Moyed; T T Nguyen; K P Bertrand
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

View more
  20 in total

1.  The TetA(K) tetracycline/H(+) antiporter from Staphylococcus aureus: mutagenesis and functional analysis of motif C.

Authors:  S L Ginn; M H Brown; R A Skurray
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

2.  Transcriptional analysis of the tet(P) operon from Clostridium perfringens.

Authors:  P A Johanesen; D Lyras; T L Bannam; J I Rood
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

Review 3.  Structure and function of efflux pumps that confer resistance to drugs.

Authors:  M Ines Borges-Walmsley; Kenneth S McKeegan; Adrian R Walmsley
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

4.  The tet(K) gene from Staphylococcus aureus mediates the transport of potassium in Escherichia coli.

Authors:  G G Guay; M Tuckman; P McNicholas; D M Rothstein
Journal:  J Bacteriol       Date:  1993-08       Impact factor: 3.490

5.  pBR322 vectors having tetracycline-dependent replication.

Authors:  John E Cronan
Journal:  Plasmid       Date:  2016-02-11       Impact factor: 3.466

6.  Mutations in the tetA(B) gene that cause a change in substrate specificity of the tetracycline efflux pump.

Authors:  G G Guay; M Tuckman; D M Rothstein
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

7.  Staphylococcus aureus Tet38 Efflux Pump Structural Modeling and Roles of Essential Residues in Drug Efflux and Host Cell Internalization.

Authors:  Q C Truong-Bolduc; Y Wang; D C Hooper
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

8.  Detection of tetracyclines and efflux pump inhibitors.

Authors:  D M Rothstein; M McGlynn; V Bernan; J McGahren; J Zaccardi; N Cekleniak; K P Bertrand
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

9.  Antibiotic Resistance Genes in Freshwater Biofilms May Reflect Influences from High-Intensity Agriculture.

Authors:  Cynthia Winkworth-Lawrence; Katharina Lange
Journal:  Microb Ecol       Date:  2016-03-01       Impact factor: 4.552

10.  Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.

Authors:  Margareta Tuckman; Peter J Petersen; Anita Y M Howe; Mark Orlowski; Stanley Mullen; Karen Chan; Patricia A Bradford; C Hal Jones
Journal:  Antimicrob Agents Chemother       Date:  2007-07-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.